Company / SG&A Expense
Sotera Health SG&A Expense History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$252.8M
FY2025
5-year range
$147.5M / $252.8M
FY2021-FY2025
Trend
+4.2%
vs FY2024
Sector context
#96 of 158
Health Care
What the data says
At $253M, Sotera Health's sg&a expense ranks #63 of 158 in the Health Care sector. SG&A Expense has increased for 4 consecutive years, from $147M in FY2021 to $253M in FY2025.
Based on SEC 10-K filings.
$253M in FY2025 with a 5-year CAGR of +7.2%.
Increased from $237M to $253M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +12.3%
- 5-Year CAGR
- +7.2%
- 10-Year CAGR
- -
Sector benchmark
#63 of 158 in Health CareTop 39% of 158This company $252.8M Sector average $175.9B
▼
-99.9% below sector average
Key checks
Key Insights
- Sotera Health's sg&a expense has grown for 4 consecutive years.
- 5-year CAGR of +7.2%, indicating consistent growth.
- In FY2025, sg&a expense increased 4.2% year-over-year.
- Ranks #96 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $252.8M | +4.2% |
| FY2024 | $242.6M | +2.5% |
| FY2023 | $236.7M | +32.6% |
| FY2022 | $178.5M | +21.1% |
| FY2021 | $147.5M | -17.4% |
| FY2020 | $178.5M | +21.1% |
| FY2019 | $147.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026